These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-ceramide antibodies in leprosy: marker for nerve damage? Singh K; Singh B; Ray P J Infect Dev Ctries; 2010 Jun; 4(6):378-81. PubMed ID: 20601789 [TBL] [Abstract][Full Text] [Related]
5. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers. Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928 [TBL] [Abstract][Full Text] [Related]
6. Anti-heparan sulfate antibodies in neurological disease. Briani C; Ruggero S; Alaedini A; Nardelli E; Ferrari S; Wirguin I; Zara G; Battistin L; Latov N Muscle Nerve; 2002 Nov; 26(5):713-5. PubMed ID: 12402295 [TBL] [Abstract][Full Text] [Related]
7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
13. [Contribution of autoantibodies to the diagnosis of peripheral neuropathies]. Antoine JC Rev Med Liege; 2004; 59 Suppl 1():133-40. PubMed ID: 15244169 [TBL] [Abstract][Full Text] [Related]
14. Associations of serum anti-ganglioside antibodies and inflammatory markers in diabetic peripheral neuropathy. Ge S; Xie J; Zheng L; Yang L; Zhu H; Cheng X; Shen F Diabetes Res Clin Pract; 2016 May; 115():68-75. PubMed ID: 27242125 [TBL] [Abstract][Full Text] [Related]
15. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls. Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071 [TBL] [Abstract][Full Text] [Related]
16. Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies? Josviak ND; Batistela MS; Souza RKM; Wegner NR; Bono GF; Sulzbach CD; Simão-Silva DP; Piovezan MR; Souza RLR; Furtado-Alle L Int J Neurosci; 2017 Dec; 127(12):1082-1086. PubMed ID: 28504037 [TBL] [Abstract][Full Text] [Related]
17. Assessment of platelets morphological changes and serum butyrylcholinesterase activity in children with diabetic ketoacidosis: a case control study. Mousa SO; Sayed SZ; Moussa MM; Hassan AH BMC Endocr Disord; 2017 Apr; 17(1):23. PubMed ID: 28376867 [TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase as a biochemical marker. Pohanka M Bratisl Lek Listy; 2013; 114(12):726-34. PubMed ID: 24329513 [TBL] [Abstract][Full Text] [Related]